{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:42Z","timestamp":1789148982783,"version":"build-2803163510"},"reference-count":5,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.3899\/jrheum.200998","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T12:40:35Z","timestamp":1622551235000},"page":"948-949","source":"Crossref","is-referenced-by-count":16,"title":["Successful Treatment With Baricitinib in a Patient With Refractory Eosinophilic Fasciitis"],"prefix":"10.3899","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8716-5286","authenticated-orcid":false,"given":"Rahul","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5975-3830","authenticated-orcid":false,"given":"Floranne C.","family":"Ernste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Eckloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"2022102905200656000_48.6.948.1","first-page":"569","article-title":"Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?","volume":"11","author":"Shulman","year":"1984","journal-title":"J Rheumatol"},{"key":"2022102905200656000_48.6.948.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker366"},{"key":"2022102905200656000_48.6.948.3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jdcr.2017.12.003","article-title":"Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib","volume":"4","author":"Kim","year":"2018","journal-title":"JAAD Case Rep"},{"key":"2022102905200656000_48.6.948.4","first-page":"567","article-title":"Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis","volume":"38","author":"Cao","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2022102905200656000_48.6.948.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-002-0006-0"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.200998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T12:20:18Z","timestamp":1667046018000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.200998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":5,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,1]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.3899\/jrheum.200998"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.200998","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}